[1]郭 俊,张建兴.颌下腺黏膜相关淋巴瘤伴大B细胞淋巴瘤转化1例报道[J].医学信息,2021,34(20):188-189.[doi:10.3969/j.issn.1006-1959.2021.20.052]
点击复制

颌下腺黏膜相关淋巴瘤伴大B细胞淋巴瘤转化1例报道()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年20期
页码:
188-189
栏目:
出版日期:
2021-10-20

文章信息/Info

文章编号:
1006-1959(2021)20-0188-02
作者:
郭 俊张建兴
广州中医药大学第二附属医院超声影像科,广东 广州 510120
关键词:
颌下腺淋巴瘤B细胞超声检查磁共振成像
分类号:
R739.81
DOI:
10.3969/j.issn.1006-1959.2021.20.052
文献标志码:
B

参考文献/References:

[1]邱国超,饶智国.肾黏膜相关淋巴组织淋巴瘤大B细胞转化1例报告[J].华南国防医学杂志,2011,25(3):272.[2]姜萍萍,曹贤,刘琦.胃黏膜相关淋巴组织淋巴瘤的不同内镜下表现[J].现代医药卫生,2017,33(1):159-160.[3]El-Naggar AK,Chan JKC,Grandis JR,et al.WHO classification of head and neck tumors[M].4th ed.Lyon:International Agency for Research on Cancer,2017:276-280.[4]Zhang T,Wu Y,Ju H,et al.Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region:A retrospective analysis of 105 patients[J].Cancer Med,2020,9(1):194-203.[5]Maeshima AM,Taniguchi H,Toyoda K,et al.Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients[J].Br J Haematol,2016,174(6):923-931.[6]Fujita A,Tajika M,Tanaka T,et al.A case of API2-MALT1-positive gastric MALT lymphoma with concomitant diffuse large B-cell lymphoma[J].Nagoya J Med Sci,2017,79(2):251-257.[7]Yang X,Xiao M,He W.Sequential development of multifocal recurrent non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient:A case report[J].Medicine,2018,97(21):e10845.[8]程芳芳,陈剑芳,杨林花.不同蛋白表达及临床特征对弥漫大B细胞淋巴瘤患者预后的影响[J].中国实验血液学杂志,2019,27(5):1490-1496.[9]Patrascu AM,Rotaru I,Olar L,et al.The prognostic role of BCL-2,Ki67,c-MYC and p53 in diffuse large B cell lymphoma[J].Rom J Morphol Embryol,2017,58(3):837-843.

相似文献/References:

[1]栾新宇,邓颖哲,李 萍.PDCA护理管理对淋巴瘤患者PICC护理效果分析[J].医学信息,2018,31(10):169.[doi:10.3969/j.issn.1006-1959.2018.10.059]
 LUAN Xin-yu,DENG Ying-zhe,LI Ping.Effect of PDCA Nursing Management on PICC Care of Patients with Lymphoma[J].Medical Information,2018,31(20):169.[doi:10.3969/j.issn.1006-1959.2018.10.059]
[2]卜 庆,池小钜.NCCN指南在淋巴瘤临床实习教学中的应用[J].医学信息,2018,31(24):28.[doi:10.3969/j.issn.1006-1959.2018.24.008]
 BU Qing,CHI Xiao-ju.Application of NCCN Guidelines in Clinical Practice Teaching of Lymphoma[J].Medical Information,2018,31(20):28.[doi:10.3969/j.issn.1006-1959.2018.24.008]
[3]曹廷智.艾滋病合并淋巴瘤的临床病例分析[J].医学信息,2019,32(11):191.[doi:10.3969/j.issn.1006-1959.2019.11.060]
 CAO Ting-zhi.Clinical Case Analysis of AIDS with Lymphoma[J].Medical Information,2019,32(20):191.[doi:10.3969/j.issn.1006-1959.2019.11.060]
[4]李 鑫,阙文君,余泽波.以冷凝集素综合征为首发表现的淋巴瘤1例[J].医学信息,2020,33(12):188.[doi:10.3969/j.issn.1006-1959.2020.12.064]
[5]徐广春.个性化护理在改善淋巴瘤化疗后血小板减少症中的作用及安全性[J].医学信息,2023,36(11):168.[doi:10.3969/j.issn.1006-1959.2023.11.036]
 XU Guang-chun.The Role and Safety of Personalized Nursing in Improving Thrombocytopenia After Lymphoma Chemotherapy[J].Medical Information,2023,36(20):168.[doi:10.3969/j.issn.1006-1959.2023.11.036]
[6]陈星妤,闵海燕,陶鹏飞,等.炎症因子在艾滋病合并淋巴瘤中的作用研究现况[J].医学信息,2024,37(03):180.[doi:10.3969/j.issn.1006-1959.2024.03.038]
 CHEN Xing-yu,MIN Hai-yan,TAO Peng-fei,et al.Research Status of the Role of Inflammatory Factors in AIDS Complicated with Lymphoma[J].Medical Information,2024,37(20):180.[doi:10.3969/j.issn.1006-1959.2024.03.038]

更新日期/Last Update: 1900-01-01